Form 4: Vyne Therapeutics Inc. Executive Iain Stuart Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
Chief Scientific Officer Iain Stuart disposed of 109 shares of Vyne Therapeutics Inc. stock to cover tax withholding requirements related to vesting restricted stock units.
Summary
- On September 30, 2024, Iain Stuart, the Chief Scientific Officer of Vyne Therapeutics Inc., disposed of 109 shares of common stock.
- The transaction was executed to satisfy tax withholding requirements associated with the vesting of restricted stock units.
- The price per share was $1.88.
- Following the transaction, Stuart directly owns 133,494 shares of Vyne Therapeutics Inc.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard transaction related to tax obligations and doesn't necessarily reflect a positive or negative outlook on the company.
Industry Context
This is a routine Form 4 filing, common for executives who have stock-based compensation. It indicates a transaction to cover tax obligations, which is a standard practice.
Stakeholder Impact
- The disposal of a small number of shares is unlikely to have a significant impact on shareholders.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of transaction: Iain Stuart disposed of 109 shares of Vyne Therapeutics Inc. |
| 10/02/2024 | Date of report signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.